VCRE
Income statement / Annual
Last year (2025), Vicore Pharma Ho's total revenue was $3.82 M,
a decrease of 96.51% from the previous year.
In 2025, Vicore Pharma Ho's net income was -$477.47 M.
See Vicore Pharma Ho,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$3.82 M |
$109.35 M |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.58 M
|
| Gross Profit |
$3.82 M
|
$109.35 M
|
$0.00
|
$0.00
|
-$3.58 M
|
| Gross Profit Ratio |
1
|
1
|
0
|
0
|
0
|
| Research and Development Expenses |
$390.35 M
|
$249.26 M
|
$276.29 M
|
$249.97 M
|
$30.05 M
|
| General & Administrative Expenses |
$67.91 M
|
$50.44 M
|
$36.92 M
|
$28.38 M
|
$2.23 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$7.67 M
|
$9.15 M
|
$155.21 K
|
| Selling, General & Administrative Expenses |
$67.91 M
|
$50.44 M
|
$44.60 M
|
$37.53 M
|
$2.39 M
|
| Other Expenses |
$0.00
|
$0.00
|
$617.00 K
|
$3.23 M
|
$154.55 K
|
| Operating Expenses |
$458.26 M
|
$299.71 M
|
$321.51 M
|
$290.73 M
|
$32.59 M
|
| Cost And Expenses |
$458.26 M
|
$299.71 M
|
$321.51 M
|
$290.73 M
|
$32.59 M
|
| Interest Income |
$23.89 M
|
$21.08 M
|
$10.54 M
|
$913.00 K
|
$70.20 K
|
| Interest Expense |
$60.00 K
|
$8.00 K
|
$2.00 K
|
$8.00 K
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$2.24 M
|
$3.42 M
|
$3.61 M
|
$3.38 M
|
| EBITDA |
-$477.41 M |
-$166.64 M |
-$307.90 M |
-$285.19 M |
-$288.55 M |
| EBITDA Ratio |
-125.08
|
-1.52
|
0
|
0
|
0
|
| Operating Income Ratio |
-119.06
|
-1.74
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$23.03 M
|
$21.47 M
|
$10.18 M
|
$1.92 M
|
-$211.92 K
|
| Income Before Tax |
-$477.47 M
|
-$168.89 M
|
-$311.33 M
|
-$288.81 M
|
-$32.80 M
|
| Income Before Tax Ratio |
-125.09
|
-1.54
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
-$256.00 K
|
-$384.00 K
|
-$384.00 K
|
-$252.70 K
|
| Net Income |
-$477.47 M
|
-$168.63 M
|
-$310.94 M
|
-$288.42 M
|
-$294.97 M
|
| Net Income Ratio |
-125.09
|
-1.54
|
0
|
0
|
0
|
| EPS |
-2.2 |
-1.1 |
-3.2 |
-3.8 |
-4.7 |
| EPS Diluted |
-2.2 |
-1.1 |
-3.2 |
-3.8 |
-4.7 |
| Weighted Average Shares Out |
$23.99 M
|
$13.68 M
|
$9.66 M
|
$7.22 M
|
$6.97 M
|
| Weighted Average Shares Out Diluted |
$23.99 M
|
$13.68 M
|
$9.66 M
|
$7.22 M
|
$6.97 M
|
| Link |
|
|
|
|
|
